01OverviewDefinition, clinical context and the essential points that orientate the chapter.
During embryonic development, paired mammary ridges extend from axilla to groin and normally regress except in the pectoral region. Persistent glandular tissue is termed polymastia, while an extra nipple is polythelia. Most clinically important accessory tissue lies in the axilla, where it can be confused with lymphadenopathy or adiposity. Its ducts and lobules respond to ovarian and pregnancy hormones like normally situated breast tissue.
The diagnosis should explain both anatomy and behaviour. Diffuse axillary tissue that enlarges during pregnancy may be physiological accessory breast, but a focal mass within it needs imaging and sometimes core biopsy. Because the same benign and malignant pathologies can arise there, clinicians should not dismiss change simply because it is outside the usual breast contour. Management depends on symptoms, diagnostic findings and patient priorities, with careful consent about scars, contour, sensation and lymphatic structures before excision.
Key points
- Accessory breast tissue results from incomplete regression of the embryological mammary ridge and occurs most often in the axilla, with or without an accessory nipple.
- Hormonal responsiveness can cause cyclical tenderness, pregnancy-related enlargement or milk secretion, which often makes previously unnoticed tissue symptomatic.
- Examination should decide whether an axillary fullness is glandular tissue, a lymph node, lipoma, epidermal cyst, hidradenitis or another soft-tissue mass.
- Accessory tissue can develop cysts, fibroadenoma, mastitis and carcinoma, so a new discrete lump, skin change or suspicious imaging feature requires targeted diagnosis.
- Ultrasound commonly establishes the tissue plane and identifies breast-like echotexture; mammography or MRI is added when needed to map extent or investigate a lesion.
- Stable asymptomatic tissue can be observed, while pain, functional restriction, recurrent inflammation, major distress or a proven lesion may justify specialist removal.
02AetiologyUnderlying causes, associations and risk factors, with why each one matters.
Mammary ridge persistence
Failure of complete regression along the embryonic milk line leaves extra nipple, ductal or lobular tissue, most commonly near the axilla.
Hormonal activation
Previously inconspicuous glandular remnants enlarge under pubertal, menstrual, pregnancy or lactational hormone stimulation and can become symptomatic.
03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.
- 1Ectopic glandular structure
Accessory lobules and ducts retain breast-specific epithelial and stromal organisation despite being anatomically separate from the pectoral breast.
- 2Cyclical and lactational response
Hormonal stimulation produces stromal oedema, lobular proliferation and sometimes milk secretion, causing tenderness and rapid pregnancy-related enlargement.
- 3Shared disease susceptibility
Because tissue is biologically mammary, it can develop the same inflammatory, benign proliferative and malignant processes as normally positioned breast tissue.
04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.
Accessory tissue usually lies in the axillary tail region but can occur anywhere along the line toward the groin. A small accessory nipple may reveal its embryological origin.
Cyclical swelling, pregnancy enlargement, tenderness or lactational secretion supports functional glandular tissue. These features can coexist with a focal lesion and do not establish benignity.
Broad soft or firm breast-like tissue differs from a discrete deep node or dermal cyst. Comparing both axillae and the pectoral breasts clarifies symmetry and continuity.
A new dominant nodule, fixation, ulceration, persistent bloody secretion or abnormal node needs the same triple-assessment reasoning as a lesion within the main breast.
05InvestigationsWhat to request, why it matters and how to interpret it.
Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.
- 01
Targeted axillary ultrasoundFirst step - Why
- Localise the structure and distinguish glandular tissue from node, cyst, lipoma or abscess.
- Interpretation and limitations
- Breast-like fibroglandular echotexture supports accessory tissue. Any discrete mass is categorised and sampled independently rather than hidden within the background tissue label.
- 02
Diagnostic mammography - Why
- Assess the pectoral breasts and include accessory tissue when positioning and field permit.
- Interpretation and limitations
- Standard views may not fully cover high axillary tissue, so a negative mammogram cannot exclude a lesion outside the detector field.
- 03
Image-guided core biopsy - Why
- Diagnose a solid or suspicious lesion arising within the accessory tissue.
- Interpretation and limitations
- Pathology is interpreted as breast tissue pathology and matched to the correct axillary target; an ordinary node sample cannot explain a separate glandular mass.
- 04
MRI for selected mapping - Why
- Define extent or investigate an unresolved lesion not adequately covered by other imaging.
- Interpretation and limitations
- MRI is problem-directed and may generate additional findings; a management-changing focus still requires correlation and tissue confirmation when feasible.
06Differential diagnosisRealistic alternatives and the features that help distinguish them.
Axillary lymphadenopathy
Nodes are discrete structures within the nodal basin and may reflect infection, vaccination, lymphoma or metastasis; ultrasound defines morphology and tissue plane.
Lipoma or adiposity
Fat produces soft diffuse fullness without characteristic fibroglandular architecture or cyclical glandular symptoms, although both can coexist.
Hidradenitis or epidermal cyst
Dermal nodules, puncta, sinus tracts and recurrent suppuration indicate skin appendage disease rather than deep accessory breast tissue.
07ManagementImmediate care, first-line treatment, alternatives and escalation.
01Pregnancy-change pathwayIdentify functional tissue without missing a lesionFirst stepDuring late pregnancy, a patient develops bilateral soft axillary fullness that is tender and enlarges with breast engorgement.+
- 1Examine both axillae and breasts, documenting whether tissue is diffuse and symmetrical and checking for a dominant mass, infection, skin lesion or abnormal node.
- 2Use ultrasound if anatomy is uncertain or any focal feature exists; avoid assuming every pregnancy-related axillary swelling is a node or abscess.
- 3Explain hormonal enlargement of accessory tissue and offer comfort and lactation advice without repeated compression that worsens pain.
- 4Arrange postpartum reassessment if swelling fails to regress or provide earlier review for focal growth, erythema, systemic illness or bloody secretion.
02Focal-mass pathwayApply breast diagnostics outside the breast moundA 43-year-old with known accessory axillary tissue finds a new hard 1.5 cm nodule within it.+
- 1Map the nodule separately from the surrounding tissue and examine pectoral breasts, axillary nodes and skin for associated abnormalities.
- 2Request targeted ultrasound and age-appropriate breast imaging, explicitly stating that the symptomatic target lies in accessory axillary breast tissue.
- 3Obtain image-guided core if the nodule is solid or suspicious and reconcile pathology with its exact target rather than with nearby nodes.
- 4Discuss the result through the breast multidisciplinary team if malignant or discordant, including staging and surgery based on actual anatomy.
03Elective-excision pathwayAddress persistent functional burdenStable benign accessory tissue repeatedly chafes, restricts arm movement and causes substantial distress despite conservative measures.+
- 1Confirm benign anatomy and absence of an unexplained focal lesion before treating the problem as elective symptom management.
- 2Record physical and psychological impact and discuss observation, supportive clothing and surgery without minimising patient priorities.
- 3During surgical consent, explain scar position, seroma, sensory change, contour irregularity, residual tissue and proximity to axillary structures.
- 4After excision, review pathology and wound outcome and provide a route for assessment of recurrent fullness or a new lump.
08ComplicationsImportant consequences, why they occur and why they matter clinically.
Pain and mechanical restriction
Engorgement, chafing and bulk can limit arm movement, exercise, clothing and sleep, particularly during pregnancy or lactation.
Mastitis or galactocele
Lactating accessory lobules may develop milk stasis, inflammation and collections that require imaging and drainage planning.
Accessory breast carcinoma
A malignant lesion may be diagnosed late when axillary location is mistaken for skin disease or nodes and standard breast views omit the target.
09Monitoring and follow-upTreatment response, safety checks and longer-term review.
- During pregnancy or lactation, monitor whether diffuse swelling follows breast fullness and whether a focal area, erythema or fever emerges.
- For observed tissue, advise return for a new dominant lump, skin tethering, bloody secretion, persistent unilateral enlargement or an abnormal node.
- After core biopsy, verify the report contains breast tissue from the mapped accessory target and not only lymphoid or adipose tissue.
- After excision, assess seroma, infection, altered sensation, shoulder comfort, contour and final histology rather than focusing only on scar healing.
10Special situationsVariants, exceptions and circumstances that change the usual approach.
Coverage can be incomplete
High axillary tissue may lie outside standard mammographic views. The request and radiographer need the external lesion map so tailored imaging covers the true target.
Lactation proves function not safety
Milk production confirms functioning mammary tissue, but that tissue can still develop mastitis, cysts and neoplasia and needs review when symptoms are atypical.
Nodes and breast can coexist
Accessory tissue does not replace the axillary nodal basin. A patient may have a mass within glandular tissue and a separate abnormal lymph node requiring independent sampling.
Anatomy shapes surgery
Excision near the axilla must balance complete symptom relief with lymphatic, nerve and contour risks. Preoperative mapping prevents an indiscriminate axillary dissection.
11Common pitfallsFrequent interpretation and management errors.
- 01
Calling all axillary fullness accessory breast tissue can miss lymphoma, metastatic nodes, hidradenitis and abscess.
- 02
Reassuring a new hard nodule because it sits outside the usual breast mound overlooks cancer arising in ectopic glandular tissue.
- 03
Relying on standard mammography without checking whether high axillary tissue entered the field creates false reassurance.
- 04
Removing diffuse tissue without discussing seroma, sensory and contour effects underestimates the morbidity of elective surgery.